← Open Payments lookup

ERIKA LEAKEY: Open Payments

NPI 1710962873 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,005 in 44 payments from 13 companies in 2025. Trend: 2023 $989 · 2024 $1,389 · 2025 $1,005

Food & beverage: $1,005
CompanyPaymentsAmount
GENZYME CORPORATION6$171
Takeda Pharmaceuticals U.S.A., Inc.7$163
Janssen Biotech, Inc.5$109
ABBVIE INC.5$106
Celltrion USA Inc.4$86
Aimmune Therapeutics, Inc.4$78
Lilly USA, LLC2$58
QOL Medical, LLC2$54
Madrigal Pharmaceuticals2$51
Ardelyx, Inc.2$45

Products named: DUPIXENT, ENTYVIO, TREMFYA, RINVOQ, VEGZELMA, ZENPEP, OMVOH, Sucraid.

Industry payments across TX — which companies pay providers there.